October 17 - 20, 2014, Dr. Lu Xianping, the president of CHIPSCREEN BIOSCIENCES in Shenzhen, was invited to attend the fourth international conference on epigenetics of tumors held in Yangzhou. he gave a speech on the theme " Discovery of an Orally Active Subtype-Selective HDAC Inhibitor, Chidamide, as an Epigenetic Modulator for Cancer Treatment " and released the discovery tour and latest research progress of CHIPSCREEN BIOSCIENCES epigenetic antitumor drug Chidamide in Shenzhen. The meeting was jointly hosted by Yangzhou University and the general hospital of the Chinese people's liberation army. Renowned scientists in the field of tumor epigenetics, professor James g Herman and professor Tim Huang, served as honorary presidents of the conference. professors James g Herman, Tim Huang, Chen Runsheng and Zhan qimin reported on the latest research progress in epigenetics as keynote speaker.